Overexpression of eIF3D in Lung Adenocarcinoma Is a New Independent Prognostic Marker of Poor Survival

Figure 2

Kaplan-Meier survival analysis of differentially expressed subunits of eIF3 for OS in LUAD patients. and values assessed by log-rank test and number of patients in each group are provided in the figure.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)